July 7, 2014 by Brian Johnson
Dr. Charles Carignan, the former CEO of Ninepoint Medical, joins BIOM as its next CEO.
BiOM has named Dr. Charles Carignan as its next CEO, replacing Tim McCarthy, who left the company this past spring.
Carignan is a 20-year medtech veteran who has held several key positions in the medical device industry, including most recently at NinePoint Medical, where he was the founder and CEO.
In addition, Carignan has served as executive vice president and chief medical officer of Novasys Medical and held the same role at Boston Scientific (NYSE:BSX). He was also the vice president of clinical research and medical affairs at Conceptus (NSDQ:CPTS), where he oversaw the clinical development of the Essure device for female sterilization.
Bedford, Mass.-based BiOM (formerly known as iWalk) is a driving force in the bionics revolution. The company’s BiOM T2 bionic ankles are part of a new generation of “smart” prosthetics that seek to restore normalized function of human limbs to amputees. The company’s bionic ankle emulates the muscle function of a human ankle using computer processors that are able to “adjust the ankle’s stiffness and propulsive torque 500 times a second,” the company says. The result is a prosthetic that can mimic a person’s natural gait, reducing many of the long-term health problems associated with prosthetic limbs. The company was founded by MIT robotics guru Hugh Herr.
